Member Info for robortsmith

amazing how easily the price has been manipulated. still 175 isnt too painful seeing as we were below 150 a week ago and as someone has said that is now the floor

odx went below the placing price briefly so if it goes down to 175 theres no need to take up the offer you can just buy them? does this mean its in their interest to keep them well above 175? gonna be impossible to sell tomorrow if you wanted to

inevitable i suppose but still going to hurt in the short term. future looks great in the med term though. was in odx when they had a placing which was 40p. now trading at 98ish

do wonder what they've been doing since july though surely trials should have been started by now? and if the government can pay 12 billion for a **** test and trace system why the **** are we having to fund this.

i prob missed this so sorry if posted but a mention yesterday

If ever there was a time to be in virus testing, tracing or treatment, it is surely 2020. Shares in Novacyt, former Aim-quoted tiddler and a PCR test maker, are up more than 100 times in the space of a year. With a market cap of £500m-plus, it is hardly tiddly now. Omega Diagnostics, another Covid-19 test maker, is up about nine times. Shares in Synairgen, which treats the virus’s symptoms, are worth about 25 times what they were a year ago. 

https://www.ft.com/content/d4f3f56f-9d0c-4e9f-bc34-1be4c390b212

good find - Dr Tristan Clark who is a consultant of synairgen's and on the advisory committee for Roche :)

as ive just found my screenshot!

100,000's of sng001 treatments in the new year for an annual recurring market

https://i.postimg.cc/BbcPtyW2/Screenshot-2020-09-22-at-19-18-45.png

so we might have a treatment for cancer that there are no other treatments for. we're in phase 3 trials for ibs treatment that there are no other treatments for. wow! surely the company will get bought - never known one with such potential?

no it was just a general can they update us as they're just sat there discussing it rather than asking han**** direct questions

Another one has just asked ministers to update them on rapid testing ASAP

Tory mp just asked gov to expedite the 20 min test at Heathrow in the commons

nice to know we have a direct line into Roche

random one not sure if posted:

Principal researcher Tristan W. Clark received fees unrelated to this study from BioFire Diagnostics and BioMerieux; consultancy fees from Synairgen Research, Randox Laboratories, and Cidara Therapeutics; is a member of an advisory board for Roche and a member of two independent data monitoring committees for trials sponsored by Roche; and has acted as the UK chief investigator for an investigational medicinal product study sponsored by Janssen. All other authors reported no competing interests.

https://www.physiciansweekly.com/covid-19-point-of-care-testing-shortens-results-time-improves-patient-flow/

the hope is its this:

Priority Medicines (PRIME)
Disclosure of information related to priority medicines cannot be released at present time as
these contain commercially confidential information

we have better mortality rates due to:

"drug discoveries by british science"

not with all of thursday's potential news coming out - should be some strong buying before then

https://edition.cnn.com/2020/10/12/health/johnson-coronavirus-vaccine-pause-bn/index.html

Johnson & Johnson pauses Covid-19 vaccine trial after 'unexplained illness'

we'll need treatments..

boris live on tv again now you never know

have asked on their board - you'd think numis were serious people with serious valuations - hopefully!

hello ncyt's,

Not invested here unfortunately but am in sng. I see we now share the same broker who has put a large value on sng today. Question for you guys is has numis done a brokers note for ncyt if so what was the value? just wondered how realistic / optimistic they normally are? have they been good for you guys?

Thanks all

what do numis value ncyt at out of interest?